MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.eururo.2025.04.008

Медицинская библиотека · European urology · 2025

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma.

Chu Carissa E, Chen Ziyu, Whiting Karissa, Ostrovnaya Irina, Lenis Andrew T, Clinton Timothy N, Rammal Rayan, Ozcan Gamze Gokturk, Akbulut Dilara, Basar Merve, Chen Jie-Fu, Chen Ying-Bei, Gopalan Anuradha, Fine Samson W, Tickoo Satish K, Arcila Maria, Brannon A Rose, Berger Michael F, Cha Eugene K, Goh Alvin C, Donahue Timothy F, Bajorin Dean F, Teo Min Yuen, Rosenberg Jonathan E, Iyer Gopa, Pietzak Eugene J, Bochner Bernard H, Reuter Victor E, Sarungbam Judy, Solit David B, Al-Ahmadie Hikmat

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND

OBJECTIVE

Divergent differentiation and histologic subtypes are common findings in urothelial carcinoma (UC). Clinically relevant genomic alterations and oncogenic drivers of individual subtypes remain poorly defined. We characterized surgical outcomes and the genomic landscape of UC with aberrant histology (UCAH), with a focus on biomarkers and targetable alterations.

METHODS

The clinical cohort comprised 3052 patients who underwent radical cystectomy (RC) with or without neoadjuvant chemotherapy. Targeted exon sequencing was performed for a genomic cohort of 1060 bladder tumors from RC or transurethral resection specimens. We characterized the frequency of oncogenic mutations and targetable alterations, and the tumor mutational burden (TMB) of each subtype. We defined the clonal relatedness of morphologically distinct regions of tumors with mixed histology.

KEY FINDINGS AND LIMITATIONS: Patients with plasmacytoid, micropapillary, sarcomatoid, or mixed-histology tumors had worse cancer-specific survival than patients with pure urothelial histology. ERBB2, FGFR3, and PTEN alterations were most frequent in micropapillary, nested/squamous, and sarcomatoid UC, respectively. TMB was highest in plasmacytoid, neuroendocrine, and micropapillary tumors. Regions of mixed histology had shared clonal origins, but exceptions were observed. The retrospective design and potential for selection bias are limitations of our study.

CONCLUSIONS AND CLINICAL IMPLICATIONS: UCAH tumors have distinct patterns of genomic alterations, which may be targetable via novel therapies and have implications for clinical trial inclusion. Biomarker-driven systemic therapy should be explored in patients with histologic subtypes that are associated with worse clinical outcomes.

Для цитирования: Chu Carissa E, Chen Ziyu, Whiting Karissa, Ostrovnaya Irina, Lenis Andrew T, Clinton Timothy N, Rammal Rayan, Ozcan Gamze Gokturk, Akbulut Dilara, Basar Merve, Chen Jie-Fu, Chen Ying-Bei, Gopalan Anuradha, Fine Samson W, Tickoo Satish K, Arcila Maria, Brannon A Rose, Berger Michael F, Cha Eugene K, Goh Alvin C, Donahue Timothy F, Bajorin Dean F, Teo Min Yuen, Rosenberg Jonathan E, Iyer Gopa, Pietzak Eugene J, Bochner Bernard H, Reuter Victor E, Sarungbam Judy, Solit David B, Al-Ahmadie Hikmat. Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma.. European urology. 2025. DOI: 10.1016/j.eururo.2025.04.008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.